about
The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and RegulationPlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 geneSurveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.Antimalarial agents: specific treatment regimens.Malaria prophylaxis.Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spreadFalciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in BurmaPrevention and treatment of malaria in pregnancy.Pharmacodynamic interaction between mefloquine and retinol in Plasmodium falciparum in vitro.Comparative clinical trial of four regimens of dihydroartemisinin-mefloquine in multidrug-resistant falciparum malaria.Development of halofantrine resistance and determination of cross-resistance patterns in Plasmodium falciparumActivity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitroCrystal structure and molecular structure of mefloquine methylsulfonate monohydrate: implications for a malaria receptor.Plasmodium falciparum: mefloquine resistance produced in vitro.Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape.
P2860
Q28551177-5A37F8A9-4EBE-43A3-90E3-4F749586C91BQ30240158-4E6B37E5-4747-4457-800E-414534691E2FQ31162495-F0161BDD-C0EC-47AB-A679-80FF3E33E813Q34560158-7BB06401-0373-47FF-92B4-59198561DEC5Q35311814-9F628200-48B0-4EB3-8F86-84F1D7B69BD5Q36521046-78D73FFA-49E6-456C-8308-D3A4926C58BEQ36722524-6B45B12B-E4B6-408C-A111-893F08EB3492Q36875917-1AAC1CF3-E945-4B9A-994D-07561E33ECB5Q37809067-AB2E27AE-29C6-4239-98C8-DD27ACBB9592Q39034428-F615F32A-0692-41A6-B50F-55EA1DDE4E66Q39288400-63015969-E636-4BF2-9252-B67F517EF2DBQ39295407-BF7645D1-56C6-429E-9338-E94ABE675B3EQ39817677-253F4337-7F58-48D6-A2FE-9A46E223155FQ40087934-CAD3E3A1-7565-4EC4-A5A2-6F6BD692521DQ41920175-0854A36F-74FC-4897-B241-4189BD2C0A1BQ50052786-4E5C4730-1B65-45A0-8E5F-964A6DB786C1
P2860
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Type II mefloquine resistance in Thailand.
@en
Type II mefloquine resistance in Thailand.
@nl
type
label
Type II mefloquine resistance in Thailand.
@en
Type II mefloquine resistance in Thailand.
@nl
prefLabel
Type II mefloquine resistance in Thailand.
@en
Type II mefloquine resistance in Thailand.
@nl
P2093
P1433
P1476
Type II mefloquine resistance in Thailand.
@en
P2093
E F Boudreau
H K Webster
K Pavanand
L Thosingha
P356
10.1016/S0140-6736(82)91532-X
P407
P577
1982-12-01T00:00:00Z